Latest news with #BoneMarrowTransplant
Khaleej Times
5 days ago
- Health
- Khaleej Times
Look: How this UAE hospital is bringing colour and hope to children's cancer unit
Yas Clinic Hospital and the Abu Dhabi Stem Cells Centre (ADSCC) have turned the walls of their pediatric Bone Marrow Transplant (BMT) unit into a series of cheerful murals as part of a new initiative called 'Colours of Hope.' The project aims to brighten the treatment journey of young patients by surrounding them with images that spark imagination and build hope. It was launched under the UAE's Year of Community campaign and painted by Mariam AlHarthi, an Emirati artist and Yas Clinic employee. One wall features cartoon-style drawings of frontline workers standing beneath a falcon. Another shows a young Emirati boy and girl wandering through a desert and coming across a treasure chest near a watchtower and palm trees. A third painting shows two gazelles. According to a press release issued by ADSCC, the murals reflect themes of discovery, strength, and national pride, helping children imagine a future beyond illness. 'Every colour that brightens the walls of our pediatric bone marrow transplant unit reflects a powerful strength I witness daily in our young patients and in our medical team at Yas Clinic Hospital and Abu Dhabi Stem Cells Centre,' said Dr Fatema Al Kaabi, executive director of the Bone Marrow Transplant Programme. 'My ongoing wish is that these vibrant paintings breathe new hope into children as they go through their treatment. Through art and imagination, we strengthen each child's resolve and celebrate a unique journey toward healing.' Dr. Mansi Sachdev, consultant in Pediatric Hematology, Oncology, and Bone Marrow Transplant, added: 'When a child enters the bone marrow transplant unit, the road ahead can seem so long and difficult. My hope is that, through 'Colours of Hope,' every child and their family finds in these paintings a source of happiness, strength, and inspiration. "These aren't just images on walls, they tell a story of renewed potential, opening a door to laughter and light even in the hardest times. We are here to heal their bodies, and with compassion and creativity, we care for their spirits as well.' ADSCC said the project is part of its ongoing effort to make the healing environment more child-friendly and emotionally supportive for both patients and their families.
Zawya
7 days ago
- Health
- Zawya
"Colors of Hope Initiative": Yas Clinic Hospital and Abu Dhabi Stem Cells Center transform Pediatric Bone Marrow Transplant unit into an artwork of hope for young patients and their families
Abu Dhabi: Within the healing walls of Yas Clinic Hospital and the Abu Dhabi Stem Cells Center, care, hope and dream now radiate from every surface of the pediatric Bone Marrow Transplant (BMT) unit. The newly inaugurated 'Colors of Hope' project is more than a collection of paintings; it's a heartfelt mission to surround every young patient, their family, and dedicated caregivers with an atmosphere of inspiration and boundless possibility. Stepping into the Bone Marrow Transplant unit takes you on an exciting journey painted across walls, a world compassionately envisioned by the Cente's and hospital leadership team, who echo their mission of providing latest innovative solution that inspire hope and confidence in our future. Brought to life by Emirati artist Mariam AlHarthi, a Yas Clinic employee. Their goal: transform the experience of serious illness into a celebration of courage and imagination, where each child is seen as a future leader, scientist, explorer, or artist. The vibrant paintings and artwork that decorate the walls of the Bone Marrow Transplant unit are inspired by the remarkable achievements and culture of the United Arab Emirates. These paintings plant seeds of confidence in young hearts, assuring each child that their dreams are possible, no matter the challenges they might face. In these halls, laughter mingles with hope, resilience sparks children's imagination, and above all, hope becomes the strongest medicine of all. Dr. Fatema Al Kaabi, Executive Director of the Bone Marrow Transplant Program at Yas Clinic Hospital and Abu Dhabi Stem Cells Center, shared: 'Every color that brightens the walls of our pediatric bone marrow transplant unit reflects a powerful strength I witness daily in our young patients and in our medical team at Yas Clinic Hospital and Abu Dhabi Stem Cells Center. My ongoing wish is that these vibrant paintings breathe new hope into children as they go through their treatment. Each painting is a promise to our children and their families that their dreams will always be treasured in our hearts. Hope is the bridge that carries families and care teams over every challenge. Through art and imagination, we strengthen each child's resolve and celebrate a unique journey toward healing.' The "Colors of Hope" initiative is part of the UAE's national "Year of Community," demonstrating how Yas Clinic Hospital and Abu Dhabi Stem Cells Center bring together art and community spirit to enhance the care of young patients. These paintings are far more than simple decorations, they are a living honour to healing, hope, and the unity of the Emirati community in all its diversity. Here, patients, families, and caregivers walk the healing journey together, hand in hand. Dr. Mansi Sachdev, Consultant in Pediatric Hematology, Oncology, and Bone Marrow Transplant, added: 'When a child enters the bone marrow transplant unit, the road ahead can seem so long and difficult. My hope is that, through 'Colors of Hope,' initiative every child and their family finds in these paintings a source of happiness, strength, and inspiration. These aren't just images on walls, they tell a story of renewed potential, opening a door to laughter and light even in the hardest times. We are here to heal their bodies, and with compassion and creativity, we care for their spirits as well.' At Yas Clinic Hospital and Abu Dhabi Stem Cells Center, "Colors of Hope" is a daily celebration of the limitless possibilities that reside within every child. About Abu Dhabi Stem Cells Center (ADSCC) Abu Dhabi Stem Cells Center (ADSCC) is a renowned healthcare institution in Abu Dhabi, UAE, specialising in advanced stem cell therapy, research, and regenerative medicine. ADSCC is the incubator of the Abu Dhabi Bone Marrow Transplant (AD-BMT©) program, the first comprehensive programme to provide autologous and allogeneic hematopoietic stem cells transplant (HSCT) for adult and paediatric patients in the UAE since 2020. As a Center of Excellence in Hematopoietic Stem Cell Transplantation accredited by the Department of Health - Abu Dhabi, ADSCC's holistic service model includes advanced research, clinical trials, translational care, and manufacturing capabilities. ADSCC has one of the region's most advanced and sophisticated research labs and a robust multidisciplinary hospital. It is the only center in the UAE to encompass a cell processing laboratory, a state-of-the-art apheresis unit, a stem cell collection unit, a Good Manufacturing Practice (GMP) laboratory, and dedicated multi-specialty outpatient clinics and inpatient wards. As the UAE's first and most experienced stem cell transplant center, ADSCC has received multiple prestigious recognitions and conducted strategic collaborations, solidifying its position as a center of excellence. In 2024, ADSCC received accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) for its cellular therapy processing laboratory, the first in UAE and one of only two in Middle East to receive this global accreditation.
Middle East
24-06-2025
- Business
- Middle East
OPEN// PM, Burjeel Holdings chairman discuss cooperation in stem cell transplant
CAIRO, June 24 (MENA) - Prime Minister Moustafa Madbouli discussed with Chairman of Burjeel Holdings Shamsheer Vayalil a proposed cooperation agreement with the group for the management and operation of the Bone Marrow Transplant (BMT) unit at Sheikh Zayed Specialized Hospital. The meeting was held on Monday at the government headquarters in the New Administrative Capital, during which Madbouli had talks with Shamsheer Vayalil and his accompanying delegation to discuss potential avenues for collaboration in the field of bone marrow transplant. The meeting was attended by Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar, and a number of officials from the Health Ministry and Burjeel Holdings. Vayalil noted that Burjeel Holdings, established in 2012, currently operates a wide network of hospitals and medical centers across the UAE and the Sultanate of Oman, as well as in several African countries, including Tunisia, Chad, South Sudan, Uganda, Tanzania, Mauritania, and Somalia, positioning the group as a key player in the medical tourism sector. He explained that Burjeel Holdings offers specialized medical services across more than 50 disciplines, including oncology, hematology, and bone marrow transplant. The group also provides accredited training programs in bone marrow transplant, nursing, and critical care. He added that partnering with the Egyptian government offers a strategic opportunity to establish Egypt as a regional center for bone marrow transplant and targeted immunotherapy, by leveraging its advanced medical tourism infrastructure, geographic proximity to key markets, and cost-effective healthcare services to attract international patients. For his part, Abdel Ghaffar stated that the partnership with Burjeel Holdings to manage and operate the bone marrow transplant unit at Sheikh Zayed Specialized Hospital aligns with the Ministry of Health and Population's strategy to advance bone marrow transplantation and targeted immunotherapy services in Egypt. It also supports the implementation of strategic partnerships with international entities possessing leading expertise in this field. This collaboration aligns with Egypt's broader strategy to stimulate investment in the healthcare sector and advance medical tourism through the provision of advanced, high-quality medical services. The minister affirmed that this partnership will support the national strategy to eliminate waiting lists for bone marrow transplant patients by expanding operational capacity across multiple hospitals beyond Sheikh Zayed Specialized Hospital. He noted that the number of bone marrow transplant beds overseen by the Specialized Medical Centers Authority (SMCA) is set to increase from 44, comprising 27 beds at the Nasser Institute and 17 at Sheikh Zayed Specialized Hospital, to a total of 100 beds by the end of 2025. The planned expansion includes the addition of 11 beds at Sheikh Zayed Specialized Hospital, five at the Sohag Oncology Center, and 40 at El-Agouza Hospital. He added that the partnership with Burjeel Holdings will further support the implementation of the National Bone Marrow Transplant Registry Project. Burjeel's international procurement capabilities enable the regular provision of medications and medical consumables required for bone marrow transplants, in full compliance with Egyptian laws and regulations, thereby contributing to the reduction of patient waiting lists. The minister further noted that the partnership will include training programs in BMT and oncology, as well as specialized training in stereotactic radiosurgery (SRS); a non-surgical radiation therapy that precisely delivers high doses of radiation to a targeted area, often within the brain or spine, and stereotactic body radiotherapy (SBRT) using the Brainlab system ( a medical technology company that develops software and hardware solutions for image-guided surgery and radiotherapy). The partnership will also include training in molecular laboratory techniques, molecular pathology, and digital pathology in cooperation with OncoHelix (Canada's leading precision diagnostics laboratory), as well as support for the introduction of CAR T-cell therapy (an innovative immunotherapy where a patient's own T cells are genetically modified to target and destroy cancer cells). (MENA) R R N/M O H
New Indian Express
30-05-2025
- Health
- New Indian Express
Experts warn of rising blood cancer cases among children, cite pollution and chemicals as key causes
BHUBANESWAR: The incidence of blood cancer or leukaemia in the country is on the upward spiral with a high number of children getting afflicted by the disease, experts said. Addressing an event organised at IMS and SUM Hospital here to mark the World Blood Cancer Day on Wednesday, head of the Hematology department, Hemato Oncology, Bone Marrow Transplant Prof Priyanka Samal said pollution, radiation and use of chemical fertiliser are among the prime causes of blood cancer. 'Though new cases of leukemia are being detected among the young children in the age group of one to 10 years, around 80 to 90 pc of the children are able to defeat the disease with proper treatment and care,' she added. The symptoms of the disease which include continued fever, fall in haemoglobin, total leukocyte count and platelet level, appearance of black spots on the body and bleeding, should not be ignored. 'Once diagnosed, it can be cured depending on the stage. We have the latest treatment regimen like bone marrow transplantation, haplo transplant and Chimeric Antigen Receptor- T (CAR-T) Cell Therapy, which have been very successful,' Dr Samal added. Eminent neurosurgeon and SOA's principal advisor (health sciences) Prof Ashok Kumar Mahapatra, dean Prof Sanghamitra Mishra, medical superintendent (MS) Prof Pusparaj Samantasinghar and MS of SUM's Phulnakhara campus Prof Rajesh Lenka spoke.
